| Issue Date | Title | Author(s) |
| 2023-04-03 | A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer. | Mayoh, C; Gifford, AJ; Terry, R; Lau, LMS; Wong, M; Rao, P; Shai-Hee, T; Saletta, F; Khuong-Quang, D-A; Qin, V; Mateos, MK; Meyran, D; Miller, KE; Yuksel, A; Mould, EVA; Bowen-James, R; Govender, D; Senapati, A; Zhukova, N; Omer, N; Dholaria, H; Alvaro, F; Tapp, H; Diamond, Y; Pozza, LD; Moore, AS; Nicholls, W; Gottardo, NG; McCowage, G; Hansford, JR; Khaw, S-L; Wood, PJ; Catchpoole, D; Cottrell, CE; Mardis, ER; Marshall, GM; Tyrrell, V; Haber, M; Ziegler, DS; Vittorio, O; Trapani, JA; Cowley, MJ; Neeson, PJ; Ekert, PG |
| 2017-11 | Programmed Death-Ligand 1 Expression in a Large Cohort of Pediatric Patients With Solid Tumor and Association With Clinicopathologic Features in Neuroblastoma. | Saletta, F; Vilain, RE; Gupta, AK; Nagabushan, S; Yuksel, A; Catchpoole, D; Scolyer, RA; Byrne, JA; McCowage, G |
| 2022-02 | Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer. | Sylvester, DE; Chen, Y; Grima, N; Saletta, F; Padhye, B; Bennetts, B; Wright, D; Krivanek, M; Graf, N; Zhou, L; Catchpoole, D; Kirk, J; Latchoumanin, O; Qiao, L; Ballinger, M; Thomas, D; Jamieson, R; Dalla-Pozza, L; Byrne, JA |
| 2022 | SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin. | Hurkmans, EGE; Koenderink, JB; van den Heuvel, JJMW; Versleijen-Jonkers, YMH; Hillebrandt-Roeffen, MHS; Groothuismink, JM; Vos, HI; van der Graaf, WTA; Flucke, U; Muradjan, G; Schreuder, HWB; Hagleitner, MM; Brunner, HG; Gelderblom, H; Cleton-Jansen, A-M; Guchelaar, H-J; de Bont, ESJM; Touw, DJ; Nijhoff, GJ; Kremer, LCM; Caron, H; Windsor, R; Patiño-García, A; González-Neira, A; Saletta, F; McCowage, G; Nagabushan, S; Catchpoole, D; Te Loo, DMWM; Coenen, MJH |
